Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Medical Device Distributor Settles False Claims Act Lawsuit for $1 Million

Jul 7, 2022 | False Claims Act

The DOJ announced that Reliance Medical Systems LLC, along with its owners and two physician-owned distributorships (PODs), have agreed to pay $1 million to settle a False Claims Act (FCA) lawsuit after the first day of trial. It is alleged that the defendants...

The Supreme Court to Resolve Circuit Splits on Government’s Authority to Dismiss Qui Tam Cases

Jun 28, 2022 | False Claims Act

The Supreme Court has granted certiorari in the Polansky v. Executive Health Resources Inc., No. 19-3810 (3d Cir. Oct. 28, 2021) matter and is expected to resolve circuit splits on whether the government has authority to dismiss a relator’s qui tam action pursuant to...

Rehab Facility Ordered to Pay $9.6 Million for Submitting False Claims to Tricare and Medicaid

Jun 8, 2022 | False Claims Act

On June 2, the United States Attorney’s Office for the Middle District of Georgia announced that a Middle District Judge had ruled in the government’s favor against Middle Georgia Family Rehab in a case involving allegedly false claims submitted to TRICARE and...

6 Physicians Accused of Violating the False Claims Act

Jun 2, 2022 | False Claims Act, Health Care Fraud

The DOJ previously filed a complaint against former True Health Diagnostics LLC (“THD”) CEO, former Boston Heart Diagnostics Corporation (“BHD”) CEO, and former Little River Healthcare (“LRH”) CEO under the False Claims Act (“FCA”) for alleged violations of the...

FCA Civil Monetary Penalty Increased for Inflation for 2022

May 19, 2022 | False Claims Act

The federal False Claims Act (“FCA”) is one of the most powerful tools frequently used by the federal government to combat fraud.  The FCA prohibits any person from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment to the...

DOJ Update on Recent COVID-19 Fraud Enforcement Actions

Apr 27, 2022 | COVID-19 Related Law, False Claims Act, Fraud Investigations, Government Investigations, Health Care

In May of 2021, the Department of Justice established the COVID-19 Fraud Enforcement Task Force to investigate claims of fraud against COVID-19 relief programs.  In March of 2022, the Department announced the appointment of Associate Deputy Attorney General Kevin...
« Older Entries
Next Entries »

Recent Posts

  • Kendrick 1, Drake 0: Federal Judge Dismisses Drake’s Claims Against Distributor Over Kendrick Lamar Diss Track
  • Medical Device Manufacturer and Distributor Pay Combined $37 Million Under False Claims Act
  • Knee Implant Manufacturer Agrees to $8 Million False Claims Act Settlement
  • Condo Conversion Planned for 2460 Peachtree Road
  • HHS-OIG Expresses “Major Concerns” About Skin Substitutes

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group